Hikma Pharmaceuticals Share Discussion Threads

[karateboy] 23/1/2017 21:33

Pharma with generic medicines should do better in Trump world as their medicines are cheaper.

[fez77] 23/1/2017 15:07

Shardview - It's up to you to take a profit if you wish. I'm going to be holding at present and seeking a level of 2,000.

[shardview] 23/1/2017 11:54

Anyone getting a bit nervous that, at least in the short/medium term, these may have peaked? They're some distance from their 1575 floor and there seems to be a fair bit of negativity around pharma at present.

[fez77] 20/1/2017 22:16

Nice.......I suspect its DARHOLD LTD again!!!!

[karateboy] 20/1/2017 21:54

145000 buy with a premium at close.

[fez77] 18/1/2017 09:43

News - 18 January - Hikma receives approval for Sodium Oxybate Oral Solution

London, 18 January 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces that its wholly owned US subsidiary, Roxane Laboratories, Inc. (Roxane), has received an approval from the US Food and Drug Administration for its Sodium Oxybate Oral Solution, 500 mg/mL, the generic equivalent to Xyrem®. Roxane's Sodium Oxybate Oral Solution is indicated for the treatment of cataplexy (sudden loss of muscle strength) and excessive daytime sleepiness in patients with narcolepsy.

[fez77] 18/1/2017 09:34

4217 shares.

Going nicely today........

[g2theary] 17/1/2017 22:59

What have you got in them Fez? I have 2300 shares I sold 1850 before the Trump speech... should have topped them back up :)

[fez77] 17/1/2017 08:31

Heading in that direction.

This is my largest current holding.

[g2theary] 17/1/2017 08:16

Overweight reiterated by JP Morgan target 2100 :)

[g2theary] 12/1/2017 08:43

Still lots of potential here :)

[g2theary] 12/1/2017 08:09

I should have retracted my 2000+ yesterday when Trump was chundering on about Pharma Comp getting away with murder :/

[pyemckay] 11/1/2017 18:18

negative comments regarding pharma.

[shardview] 11/1/2017 16:50

Afternoon all,

Can anyone explain the last minute price drop? I didn't hear anything negative in Trumps speech. Seems odd to have dropped so sharply after regaining position all day.

SV

[g2theary] 10/1/2017 08:10

2000+ by the end of the week

[fez77] 05/1/2017 17:23

A strong rise - well deserved. I will reassess position at 2,000, but my current thinking is to hold up to at least 2,200.

[g2theary] 05/1/2017 14:06

Indeed all good here :)

[sawadee3] 05/1/2017 12:37

Stairway to heaven :-)

Happy days chaps :-)

[fez77] 05/1/2017 08:51

Thanks broadwood. HIK going well anyway!

[broadwood] 05/1/2017 08:46

Fez - sorry no. Obviously I mixed it up with the JPM rec.

Have removed.

[fez77] 05/1/2017 08:41

Hik going well today! Heading for 2,000.

[fez77] 05/1/2017 08:38

broadwood - is HIK mentioned in Numis article?

[broadwood] 05/1/2017 07:41

And JPMorgan.

Vecutra is given an 'overweight' rating, as is Hikma also around generic Advair upside, "which could drive significant upgrades for 2018 and beyond".

[linton5] 04/1/2017 10:09

Yea I was to slow there they pushed there luck the mms with that quick purge for stop losses lol